These are novel findings, and shed a new light on the pathogenesis of NAFLD, as we demonstrated for the first time that a relative deficiency in LAL activity is specific for NAFLD and appears since the early stages of the disease. The gene discussed is LIPA; the disease is metabolic dysfunction-associated steatotic liver disease.